Skip to main content

Oaktree Acquisition Corp. III Life Sciences 10-Q for FY2026 Q3

Oaktree Acquisition Corp. III Life Sciences (OACC)

10-Q 2026-11-13 For: 2026-09-30
View Original
Added on November 14, 2026

About this 10-Q

Oaktree Acquisition Corp. III Life Sciences filed this 10-Q on November 13, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

Oaktree Acquisition Corp. III Life Sciences extended its combination deadline to November 25, 2026, after holders of 11,331,102 public shares redeemed them for an aggregate $122,435,287, leaving an approximately $85.0 million trust balance and substantial doubt about going concern. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$452.55K
compared with net income of $1.97M a year earlier